Economic burden and dosing trends of buprenorphine buccal film and transdermal patch in chronic low back pain

References

• Vlaeyen JWS, Maher CG, Wiech K, et al. Low back pain. Nat Rev Dis Primers. 2018;4(1):52. doi:10.1038/s41572-018-0052-1
   PubMed Web of Science ®Google Scholar
• Urits I, Burshtein A, Sharma M, et al. Low back pain, a comprehensive review: pathophysiology, diagnosis, and treatment. Curr Pain Headache Rep. 2019;23(3):23. doi:10.1007/s11916-019-0757-1
   PubMed Web of Science ®Google Scholar
• Chen S, Chen M, Wu X, et al. Global, regional and national burden of low back pain 1990–2019: a systematic analysis of the Global Burden of Disease study 2019. J Orthop. 2022;32:49–58. doi:10.1016/j.jot.2021.07.005
   Google Scholar
• Manchikanti L, Singh V, Falco FJE, et al. Epidemiology of low back pain in adults. Neuromodulation. 2014;17:3–10. doi:10.1111/ner.12018
   PubMed Web of Science ®Google Scholar
• Shmagel A, Foley R, Ibrahim H. Epidemiology of chronic low back pain in US adults: data from the 2009–2010 National Health and Nutrition Examination Survey. Arthritis Care Res. 2016;68(11):1688–1694. doi:10.1002/acr.22890
   PubMed Web of Science ®Google Scholar
• Stevans JM, Delitto A, Khoja SS, et al. Risk factors associated with transition from acute to chronic low back pain in US patients seeking primary care. JAMA Netw Open. 2021;4(2):e2037371. doi:10.1001/jamanetworkopen.2020.37371
   PubMed Web of Science ®Google Scholar
• Kim LH, Vail D, Azad TD, et al. Expenditures and health care utilization among adults with newly diagnosed low back and lower extremity pain. JAMA Netw Open. 2019;2(5):e193676. doi:10.1001/jamanetworkopen.2019.3676
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514–530. doi:10.7326/M16-2367
   PubMed Web of Science ®Google Scholar
• North American Spine Society (NASS). Evidence-based clinical guidelines for multidisciplinary spine care: diagnosis and treatment of low back pain. 2020 [ updated 2020 Aug 10; cited 2024 Mar 15]. Available from: http://www.spine.org/Portals/0/assets/downloads/ResearchClinicalCare/Guidelines/LowBackPain.pdf
   Google Scholar
• Department of Veteran Affairs (VA) and Department of Defense (DoD). VA/DoD clinical practice guideline for the diagnosis and treatment of low back pain v3.0. 2022 [ updated 2023 May 11; cited 2024 Mar 15]. Available from: http://www.healthquality.va.gov/guidelines/pain/lbp/
   Google Scholar
• Fine PG, Mahajan G, McPherson ML. Long-acting opioids and short-acting opioids: appropriate use in chronic pain management. Pain Med. 2009;10(Suppl. 2):S79–S88. doi:10.1111/j.1526-4637.2009.00666.x
   PubMed Web of Science ®Google Scholar
• Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review. Ann Intern Med. 2015;162(4):276–286. doi:10.7326/M14-2559
   PubMed Web of Science ®Google Scholar
• Chou R, Deyo R, Devine B, et al. The effectiveness and risks of long-term opioid treatment of chronic pain: evidence report/technology assessment no. 218. AHRQ. 2014; 14-E005-EF. doi:10.23970/AHRQEPCERTA218
   Google Scholar
• Drug Enforcement Administration (DEA). Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule. Fed Regist. 2002;67(194):62354–62370.
   PubMedGoogle Scholar
• Pergolizzi JV Jr, Raffa RB. Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. J Pain Res. 2019;12:3299–3317. doi:10.2147/JPR.S231948
   PubMed Web of Science ®Google Scholar
• Gudin J, Fudin J. A narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain. Pain Ther. 2020;9(1):41–54. doi:10.1007/s40122-019-00143-6
   PubMed Web of Science ®Google Scholar
• Webster L, Gudin J, Raffa RB, et al. Understanding buprenorphine for use in chronic pain: expert opinion. Pain Med. 2020;21(4):714–723. doi:10.1093/pm/pnz356
   PubMed Web of Science ®Google Scholar
• Elkader A, Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin Pharmacokinet. 2005;44(7):661–680. doi:10.2165/00003088-200544070-00001
   PubMed Web of Science ®Google Scholar
• Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl. 1):S31–S34. doi:10.4103/sja.SJA_543_18
   PubMed Web of Science ®Google Scholar
• Stanicic F, Grbic D, Vukicevic D, Zah V. Treatment characteristics of chronic low back pain patients treated with buprenorphine buccal film or transdermal patch. Pain Manag. 2024;14(1):35–48. doi:10.2217/pmt-2023-0124
   PubMed Web of Science ®Google Scholar
• Merative. Merative™ MarketScan® Research Databases. 2023 [ cited 2024 April 15]. Available from: https://www.merative.com/real-world-evidence
   Google Scholar
• Gore M, Sadosky A, Stacey BR, et al. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine. 2012;37(11):E668–E677. doi:10.1097/BRS.0b013e318241e5de
   PubMed Web of Science ®Google Scholar
• Spears CA, Hodges SE, Kiyani M, et al. Health care resource utilization and management of chronic, refractory low back pain in the United States. Spine. 2020;45(20):E1333–e1341. doi:10.1097/BRS.0000000000003572
   PubMed Web of Science ®Google Scholar
• Hale M, Gimbel J, Rauck R. Buprenorphine buccal film for chronic pain management. Pain Manag. 2020;10(4):213–223. doi:10.2217/pmt-2020-0013
   PubMed Web of Science ®Google Scholar
• Abdel Shaheed C, Maher CG, Williams KA, et al. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958–968. doi:10.1001/jamainternmed.2016.1251
   PubMed Web of Science ®Google Scholar
• Hale M, Garofoli M, Raffa RB. Benefit-risk analysis of buprenorphine for pain management. J Pain Res. 2021;14:1359–1369. doi:10.2147/JPR.S305146
   PubMed Web of Science ®Google Scholar
• Wong SSC, Chan TH, Wang F, et al. Analgesic effect of buprenorphine for chronic noncancer pain: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2023;137(1):59–71. doi:10.1213/ANE.0000000000006467
   PubMed Web of Science ®Google Scholar